Evidence map›Paper›PMID 23569986›Full record

Trial reportAsian Pacific journal of tropical biomedicine2012

Science behind cisplatin-induced nephrotoxicity in humans: a clinical study.

P A Arunkumar, G L Viswanatha, N Radheshyam, H Mukund, M S Belliyappa

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Asian Pacific journal of tropical biomedicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Modulatory role of garlic (F1000Research · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Danshen modulates Nrf2-mediated signaling pathway in cisplatin-induced renal injury.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2017
    Article
  15. Phytochemical evaluation of roots ofSaudi journal of biological sciences · 2017
    Article
  16. Article
  17. Article
  18. Medicines (Basel, Switzerland) · 2017
    Article
  19. CD4 T cell knockout does not protect against kidney injury and worsens cancer.Journal of molecular medicine (Berlin, Germany) · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

P A ArunkumarDepartment of Pharmacology, PES College of Pharmacy, Bangalore-560 050, India.
G L Viswanatha
N Radheshyam
H Mukund
M S Belliyappa
PES University · INSt.John's Medical College Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the relationship between serum electrolyte changes and cisplatin induced nephrotoxicity.

methodsWe collected data from 18 patients undergoing cisplatin chemotherapy including serum electrolytes, creatinine, blood urea nitrogen (BUN) and urine potassium, sodium and pH levels before and after the cisplatin chemotherapy. All the patients had cancer and were treated with 40-50 mg/day cisplatin. Renal injury was assessed by measuring serum electrolytes, creatinine, BUN levels and urine potassium, sodium and pH levels.

resultsThe five cycles of cisplatin based chemotherapy resulted in hypomagnesia (P=0.029), hypocalcaemia (P=0.001*), hypophosphatemia (P=0.003*), hypokalemia (P=0.001*) and increased serum creatinine (P=0.001*) and BUN (P=0.292*) levels. In urine analysis, decrease in potassium (P=0.024*) was found, except potassium there was no significant changes in sodium and urine pH.

conclusionsThe present study demonstrates that, acute nephrotoxicity was observed in patients with different types of cancers undergoing cisplatin based chemotherapy due to electrolyte disturbances, when no corrective measures were initiated.

Indexed as

Acute Kidney InjuryAdultAgedAntineoplastic AgentsCisplatinFemaleHumansKidneyMaleMiddle AgedNeoplasmsProspective StudiesWater-Electrolyte BalanceAntineoplastic AgentsCisplatinCisplatinCreatinineElectrolyte imbalanceHypocalcaemiaHypomagnesia

Identifiers

PMID23569986
PMCPMC3609353
OpenAlexW2024978248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.